![Robert Levin](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Patrimonio netto: 3 M $ in data 31/07/2026
Robert S.
Levin worked as a Director at Venturis Therapeutics, Inc.
| Società | Data | Numero di azioni | Valutazione | Data di valutazione |
|---|---|---|---|---|
Dyadic International, Inc.
 Dyadic International, Inc. Medical/Nursing ServicesHealth Services Manufactures genes and other biological products 9% | 24/07/2026 | 3.280.272 ( 9% ) | 3 M $ | 31/07/2026 |
| Società | Posizione | Fine |
|---|---|---|
Venturis Therapeutics, Inc.
 Venturis Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Researches therapeutic regimens to treat patients with coronary artery disease | Direttore/Membro del Consiglio | - |
Attive
Inattive
Società nel listino
Aziende private
| Aziende private | 1 |
|---|---|
Venturis Therapeutics, Inc.
Venturis Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Researches therapeutic regimens to treat patients with coronary artery disease | Commercial Services |
Seleziona la tua edizione
Tutte le informazioni finanziarie adattate in base al livello nazionale
